AlveoliX AG

AlveoliX provides in-vitro solutions based on proprietary and unique organ-on-chip technologies aimed at improving preclinical decision-making and thus reducing drug development costs. They want to make organs-on-chip technology the new standard for preclinical decision-making and bring data from bench to clinic. Their organs-on-chip will make drug discovery safer, better and personalized.